What Is a Subsequent Importer Under MDR 2017?

The Indian medical device sector operates under the regulatory framework established by the Medical Devices Rules, 2017 (MDR 2017). One important mechanism that facilitates the appointment of additional authorised agents while maintaining regulatory oversight is the Subsequent Importer pathway.

What Is a Subsequent Importer of a Medical Device?

A Subsequent Importer is an authorised agent of a foreign manufacturer who seeks an import licence for a medical device or in-vitro diagnostic (IVD) that has already been licensed to another authorised agent, where the legal and actual manufacturing site remains the same.

The CDSCO FAQs recognise the ability of a foreign manufacturer to have multiple authorised Indian agents for the same product where the legal and actual manufacturer is the same. The additional authorised agent can apply for its own import licence by referring to the existing approval and submitting the documents applicable to the Subsequent Importer pathway.

This mechanism is particularly relevant to foreign manufacturers that want to appoint multiple authorised agents or distributors in India while maintaining separate regulatory licences for each authorised agent.

Can a Foreign Manufacturer Have Multiple Importers in India?

Yes. Under the regulatory framework applicable to medical devices, a foreign manufacturer may appoint more than one authorised Indian agent for the same medical device, subject to the applicable requirements.

Each authorised agent must obtain its own import licence. The fact that another authorised agent already holds a licence for the same device does not make the second agent automatically authorised to import the device. The subsequent authorised agent must complete the applicable CDSCO licensing process.

This arrangement can support multi-channel distribution and allow manufacturers to work with different authorised agents or distribution networks in India.

Subsequent Importer vs. First Authorised Agent

The Subsequent Importer pathway differs from the application made by the first authorised agent primarily because CDSCO can refer to the existing approval for the same device and manufacturing site.

The subsequent applicant is not required to simply repeat all product- and site-related documentation already submitted for the earlier approval. Instead, the applicant must provide the documents prescribed for the Subsequent Importer pathway and demonstrate that the relevant approved manufacturing-site and product information remains applicable.

It is preferable to use the terms “first authorised agent” or “earlier licence holder” rather than treating “primary importer” as a formal regulatory category.

Both the earlier licence holder and subsequent authorised agent remain responsible for the regulatory obligations applicable to their respective licences and activities.

CDSCO Subsequent Importer Provision Under MDR 2017

The Subsequent Importer concept was already recognised in CDSCO's medical-device FAQs before 2025. In September 2025, however, CDSCO introduced a dedicated online provision for Subsequent Importers.

Through Circular No. MED-13011/16/2025-eoffice dated 15 September 2025, CDSCO announced that a separate Subsequent Importer provision had become functional on the online system with effect from 11 September 2025 for already approved Medical Devices and IVDs.

The dedicated online provision was intended to streamline the application process and provide a specific route for additional authorised agents seeking licences for already approved products.

Applicants should use the current Subsequent Importer option and checklist available on the CDSCO online system when submitting an application.

How to Apply as a Subsequent Importer of Medical Devices

The application process generally involves the following steps:

1. Confirm that the device is already approved/licensed under the applicable CDSCO framework.
2. Confirm that the legal and actual manufacturing site is the same as that associated with the existing approval.
3. Confirm the applicant's eligibility to apply for an import licence, including the applicable wholesale, manufacturing or Form MD-42 requirements.
4. Obtain the required Power of Attorney appointing the applicant as the authorised agent.
5. Prepare the Subsequent Importer application in Form MD-14.
6. Reference the existing import licence associated with the already approved device.
7. Upload the documents prescribed in the current CDSCO Subsequent Importer checklist.
8. Pay the applicable fees prescribed under the Medical Devices Rules, 2017.
9. Respond to any queries raised by CDSCO, where applicable.
10. Upon approval, obtain the import licence in Form MD-15.

The exact documents and portal requirements should always be checked against the current CDSCO online checklist before filing because portal requirements and supporting-document requirements may be updated.

Subsequent Importer Documentation Requirements

The documents required will depend on the product, existing approval and applicable CDSCO requirements. The Subsequent Importer application may include documents such as:

• Form MD-14 application and applicable fees.
• A copy of the earlier import licence.
• Power of Attorney from the overseas manufacturer appointing the applicant as the authorised agent.
• Authorised-agent undertaking, wherever applicable.
• Valid wholesale licence, manufacturing licence or Form MD-42 registration certificate, as applicable.
• Constitution and applicant details, where required.
• Manufacturer's undertaking confirming that there has been no relevant change to the approved Device Master File (DMF), Plant Master File (PMF) and other applicable regulatory documentation.
• Applicable Free Sale Certificate or Marketing Authorisation documentation, where required.
• Applicable Quality Management System certificates.
• Declaration of Conformity and other product-related regulatory documents, where applicable.
• Product labelling and Instructions for Use (IFU) complying with the applicable provisions of MDR 2017.

The above should be treated as an indicative list rather than a substitute for the current CDSCO portal checklist. Applicants should follow the checklist displayed in the Subsequent Importer application module at the time of filing.

Same Manufacturing Site Requirement

An important condition of the Subsequent Importer mechanism is that the device must relate to the same legal and actual manufacturing site associated with the existing approval.

The subsequent applicant should therefore carefully verify the manufacturer details, manufacturing-site information and product information against the earlier licence before filing.

If there has been a relevant change in the approved manufacturing arrangements or regulatory documentation, the applicant should first determine whether the change needs to be addressed through a separate regulatory procedure rather than assuming that the Subsequent Importer pathway remains applicable.

Power of Attorney for a Subsequent Importer

The foreign manufacturer must appoint the subsequent applicant as its authorised agent through the appropriate Power of Attorney.

The Power of Attorney should be prepared and authenticated in accordance with the applicable CDSCO requirements and should clearly establish the relationship between the overseas manufacturer and the proposed authorised agent.

A subsequent applicant should not rely merely on the Power of Attorney issued to another authorised agent. The applicant should submit the Power of Attorney applicable to its own appointment.

Brand Approval and Endorsement

CDSCO's September 2025 circular also addressed the procedure for Brand Approval, stating that the process had been simplified and separated from routine endorsement applications.

This development is relevant to manufacturers and authorised agents dealing with brand-related applications for already approved devices.

However, brand-related applications should be submitted according to the current CDSCO portal requirements and checklist applicable at the time of filing. Applicants should not assume that a new brand can automatically be added to an existing approval without satisfying the applicable requirements.

Responsibilities of a Subsequent Importer

Obtaining a separate import licence does not eliminate the regulatory responsibilities of the subsequent authorised agent.

The licence holder must comply with the requirements applicable to its licensed activities, including, as applicable:

• Compliance with the conditions of the import licence.
• Compliance with applicable labelling requirements.
• Proper storage and transportation of medical devices.
• Complaint handling and relevant regulatory communication.
• Post-market surveillance.
• Adverse-event and safety reporting where applicable.
• Cooperation with the manufacturer and regulatory authorities.
• Corrective actions and recalls where required.
• Maintenance of applicable records and documentation.

The subsequent importer therefore has its own regulatory responsibilities even though it relies on an existing approval for the device and manufacturing site.

Is a Subsequent Importer Licence the Same as the Earlier Import Licence?

No.

The subsequent authorised agent obtains its own Form MD-15 import licence. The existence of an earlier licence does not make the subsequent agent a party to that licence.

The subsequent agent must therefore comply with the conditions applicable to its own licence and remains responsible for the regulatory obligations associated with its activities in India.

Subsequent Importer Under India MDR 2017 vs. Importer Under EU MDR

The Indian Subsequent Importer mechanism should not be confused with the importer concept under the European Medical Device Regulation (EU MDR).

The EU MDR does not establish a separate regulatory category called a “Subsequent Importer” equivalent to the Indian mechanism. Instead, an importer is an economic operator with specific responsibilities under Article 13 of Regulation (EU) 2017/745.

Among other obligations, an EU MDR importer must verify relevant matters such as:

• CE marking.
• Availability of the EU Declaration of Conformity.
• Manufacturer and authorised representative information.
• Applicable labelling and instructions for use.
• Applicable UDI requirements.
• Registration requirements.
• Appropriate storage and transport conditions.
• Complaint and non-conformity handling.
• Cooperation with manufacturers, authorised representatives and competent authorities.

Therefore, the Indian Subsequent Importer mechanism and the EU MDR importer role serve different regulatory purposes and should not be treated as equivalent legal categories.

EUDAMED and Medical Device Importers

EUDAMED is the European Union's database for medical devices and economic operators. It forms part of the EU medical-device regulatory framework and is separate from India's CDSCO licensing system.

The EUDAMED framework has also evolved significantly. From 28 May 2026, the first four EUDAMED modules became mandatory to use, including the Actor Registration and UDI/Device Registration modules.

Companies operating in both India and the European Union should therefore maintain separate regulatory processes for the Indian CDSCO framework and the EU MDR/EUDAMED framework.

Benefits of the Subsequent Importer Pathway

For eligible products and applicants, the Subsequent Importer mechanism can provide a practical route for expanding distribution in India without requiring every additional authorised agent to repeat the entire product and manufacturing-site documentation process associated with the earlier approval.

It can help foreign manufacturers:

• Appoint additional authorised Indian agents.
• Establish multiple distribution channels.
• Maintain separate import licences for different authorised agents.
• Expand commercial reach while retaining regulatory oversight.
• Avoid unnecessary duplication of documentation already available to CDSCO, subject to the requirements of the Subsequent Importer pathway.

The mechanism does not remove the need for regulatory compliance. Each authorised agent remains responsible for complying with the requirements applicable to its own licence and activities.

Why Choose MDR Consultants?

Selecting an experienced regulatory partner can help manufacturers and authorised agents navigate the CDSCO medical-device licensing process efficiently.

MDR Consultants provides support in areas including:

• Understanding the Subsequent Importer pathway.
• Preparing and reviewing application documentation.
• Coordinating with overseas manufacturers for Power of Attorney and undertakings.
• Preparing Form MD-14 applications.
• Supporting submissions through the CDSCO online system.
• Responding to regulatory queries.
• Assisting with brand approval and post-approval regulatory requirements.
• Supporting both first authorised-agent and Subsequent Importer strategies.
• Providing regulatory guidance based on the applicable product classification and requirements.
• Supporting foreign manufacturers in establishing compliant multi-agent distribution arrangements in India.

Regulatory requirements and portal checklists can change over time. Accordingly, applications should be prepared against the requirements applicable at the time of submission.

Conclusion

The Subsequent Importer pathway under the Medical Devices Rules, 2017 provides a regulatory route for an additional authorised agent to obtain an import licence for an already approved medical device or IVD where the applicable manufacturing-site requirements are satisfied.

CDSCO has recognised the possibility of multiple authorised Indian agents for the same product and manufacturing site. Each authorised agent must obtain its own import licence and comply with the regulatory obligations applicable to that licence.

The September 2025 CDSCO circular further introduced a dedicated online Subsequent Importer provision, which became functional from 11 September 2025. This provides applicants with a specific online route for applications relating to already approved medical devices and IVDs.

Applicants should pay particular attention to the existing import licence, legal and actual manufacturing-site details, Power of Attorney, manufacturer undertakings and the current CDSCO Subsequent Importer checklist.

For companies planning multi-agent distribution in India, understanding the distinction between the first authorised agent and a Subsequent Importer, as well as the continuing responsibilities of each licence holder, is essential for maintaining regulatory compliance.

The Indian Subsequent Importer mechanism should also be distinguished from the EU MDR importer role. While India's framework provides a specific pathway for additional authorised agents, the EU MDR treats importers as economic operators with defined obligations under Article 13, supported by the EUDAMED regulatory infrastructure.

Careful preparation of the application and verification of the latest CDSCO requirements can help applicants avoid documentation gaps and regulatory delays when seeking an import licence under the Subsequent Importer pathway.

Last Updated : 22 Sep 2026